Main Menu
Menu

Fact Checks

Publish Date
BlogFact Checks
Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act

A coalition of anti-patent groups — including the R Street Institute, the Electronic Frontier Foundation, Public Knowledge, and others — recently sent...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

BlogFact Checks
Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the...

BlogFact Checks
Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation

Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for...

BlogFact Checks
Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors

A bipartisan group of legislators led by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE) recently reintroduced two critical bills to Congress:...

BlogFact Checks
Two IP-Related Bills Would Harm U.S. Innovation, Not Help It

Congress is considering several ill-conceived bills that purport to address abuses in the patent system, but would in reality weaken core intellectual...

BlogFact Checks
Fact Check: Misguided Attacks on Follow-On Patents Would Harm Patients

Critics of the U.S. patent system are increasingly targeting follow-on innovation in the biopharmaceutical sector. In an effort to weaken follow-on patents...

Blog:

Blog, Fact Checks:

Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act,

12/19/2025
Blog:

Blog, Fact Checks:

Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.,

12/04/2025
Blog:

Blog, Fact Checks:

Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”,

11/21/2025
Blog:

Blog, Fact Checks:

Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards,

10/30/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025
Blog:

Blog, Fact Checks:

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry,

09/19/2025
Blog:

Blog, Fact Checks:

Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.,

08/14/2025
Blog:

Blog, Fact Checks:

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation,

07/25/2025
Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors,

06/18/2025
Fact Checks:

Blog, Fact Checks:

Two IP-Related Bills Would Harm U.S. Innovation, Not Help It,

05/21/2025
Blog:

Blog, Fact Checks:

Fact Check: Misguided Attacks on Follow-On Patents Would Harm Patients,

04/16/2025
Scroll to Top